touchONCOLOGY were honoured to catch Françoise Meunier, Vice President, Federation of European Academies of Medicine (FEAM), at the ECCO 2019 European Cancer Summit in Brussels to discuss the latest key legislative achievements in respect to protecting cancer survivors from financial discrimination.
1. What long-term effects does cancer have on successfully treated survivors? (0:08)
2. Is a return to normal life after cancer treatment difficult for many patients? (1:04)
3. Is there currently sufficient awareness of issues faced by this survivor population among physicians and are they able to assist with their needs? (1:45)
4. What is the duration of these post-cancer effects? Are particular types of cancer or groups of patients more likely to suffer them? (2:48)
Françoise Meunier has no conflicts of interest to declare in relation to this video.
Filmed in partnership with the European Cancer Organisation at the ECCO 2019 European Cancer Summit in Brussels, Belgium.
Share this Video
Related Videos In Policy
Stefan Gijssels, Eureopean Cancer Summit 2020 – The Beating Cancer Plan
touchONCOLOGY means Stefan Gijssels at the European Cancer Summit 2020 to discuss the Beating Cancer Plan and key highlights and outcomes from this year’s meeting. Questions How do you expect the cancer burden in Europe to change in the coming years? What are the aims and main components of the Beating Cancer Plan? What initiatives […]
Françoise Meunier, European Cancer Summit 2020 – Financial Toxicity and the ‘Right to be Forgotten’
Dr Françoise Meunier, Vice President of the Federation of European Academies of Medicine, joins touchONCOLOGY to discuss financial toxicity in patients with cancer and progress made with the “Right to be Forgotten” resolution made at the European Cancer Summit in 2018. Questions What does the term ‘financial toxicity’ mean, and what does it mean for […]
Daniel Kelly, European Cancer Summit 2020 – HPV Action Network
touchONCOLOGY joins Prof. Daniel Kelly to discuss the aims and scope of the European Cancer Organisation HPV Action Network. Questions What are the aims of the HPV Action Network? How can HPV-associated cancers be reduced and why is this resolution important? Could you tell us about the European Cancer Organisation’s recent action plan and report, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!